Ftse Mib
33.961,24
0,99%
DAX
18.164,22
0,95%
S&P 500
5.156,26
0,56%
NASDAQ
16.255,76
0,62%
Bitcoin
63.452,17
-0,85%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Opko Health Inc (OPK) Opko Health Inc (OPK) Notizie

Opko Health Inc

OPK
1,31
0,01 (0,77%)
Ultimo aggiornamento: 17:17:35
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/5/202414:00GLOBEOPKO Health to Report First Quarter 2024 Financial Results..
28/3/202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
20/3/202413:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
07/3/202422:02EDGAR2Form ARS - Annual Report to Security Holders
05/3/202414:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
01/3/202422:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
28/2/202415:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
22/2/202422:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
16/2/202422:53EDGAR2Form PRE 14A - Other preliminary proxy statements
09/2/202422:07EDGAR2Form 8-K - Current report
05/2/202414:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
29/1/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:00EDGAR2Form 8-K - Current report
17/1/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:09EDGAR2Form 8-K - Current report
09/1/202422:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
08/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
05/1/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202413:00EDGAR2Form 8-K - Current report
05/1/202405:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
03/1/202423:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
28/11/202313:00PRNUSBioReference Health and Prognos Health Collaborate to..
13/11/202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202312:45PRNUSBioReference® Signs On as the First Laboratory to Use..
06/11/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:06EDGAR2Form 8-K - Current report
06/11/202322:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
02/11/202315:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
31/10/202321:08EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202313:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
25/10/202322:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
28/9/202323:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
28/9/202322:09EDGAR2Form 8-K - Current report
28/9/202322:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
12/9/202314:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
03/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:07EDGAR2Form 8-K - Current report
03/8/202322:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
25/7/202322:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
30/6/202322:10EDGAR2Form 8-K - Current report
28/6/202312:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..
Apertura: 1,29 Min: 1,29 Max: 1,32
Chiusura: 1,30

La tua Cronologia

NASDAQ
OPK
Opko Health
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network